Clinical Trials Directory

Trials / Completed

CompletedNCT03731819

Establishment of Abbreviated Pancreatobiliary MRI Protocol

Establishment of Abbreviated Pancreatobiliary MRI Using Compressed Sensing Technique for Pancreas Cystic Neoplasm Follow-up

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to establish abbreviated PB MRI protocol for patients on regular imaging follow-up for pancreas cystic neoplasm.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAbbreviated PB MRIAbbreviated PB MRI which targets table time of 10 minutes. For MRI acquisition, standard dose of commercially available MR contrast agent (Gadovist, Bayer, Germany) is used on weight-based dosing (0.1mmol/kg).

Timeline

Start date
2018-11-05
Primary completion
2019-11-12
Completion
2022-05-04
First posted
2018-11-06
Last updated
2022-05-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03731819. Inclusion in this directory is not an endorsement.

Establishment of Abbreviated Pancreatobiliary MRI Protocol (NCT03731819) · Clinical Trials Directory